Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer

Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Thompson, A. M., Rea, D. W., Stos, P. M., Shepherd, L. E., Stambolic, V., & Parulekar, W. R. (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology, 41(35), 5356–5362. https://doi.org/10.1200/jco.23.00296
Authors:
Pamela J. Goodwin
Bingshu E. Chen
Karen A. Gelmon
Timothy J. Whelan
Marguerite Ennis
Julie Lemieux
Jennifer A. Ligibel
Dawn L. Hershman
Ingrid A. Mayer
Timothy J. Hobday
Judith M. Bliss
Priya Rastogi
Manuela Rabaglio
Alastair M. Thompson
Daniel Rea
Paul M. Stos
Lois E. Shepherd
Vuk Stambolic
Wendy R. Parulekar
Affiliated Authors:
Dawn L. Hershman
Publication Type:
Article
Unique ID:
10.1200/jco.23.00296
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: